Please find enclosed the Standalone Unaudited Financial results for the Quarter and Half year ended 30th September, 2025 along with the Limited Review Report of the Statutory Auditors as ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
KMC Speciality Hospitals reported strong Q2 FY26 results with revenue from operations of Rs 7,490.19 lakhs, up about 33% from Rs 5,623.07 lakhs in Q2 FY25. Profit after tax (PAT) jumped to Rs 1,084.11 lakhs from Rs 388.41 lakhs, a rise of roughly 179% year-on-year, with EPS at Rs 0.66 versus Rs 0.24. For the first half (H1 FY26), revenue rose about 29% to Rs 14,145.48 lakhs and PAT nearly doubled to Rs 1,837.62 lakhs versus Rs 939.13 lakhs in H1 FY25. PBT margin expanded sharply to about 19.4% in Q2 from 9.4% a year earlier, while operating cash flow for H1 remained healthy at Rs 3,067.68 lakhs. Statutory auditor Deloitte Haskins & Sells issued an unmodified (clean) limited review report, and the company continues to operate in a single segment – Medical and Healthcare Services.
Strong double-digit revenue growth and a sharp jump in profitability and margins are positive for shareholders and likely supportive of the stock. Clean audit report from a big-name auditor boosts confidence in the numbers.